These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38537973)

  • 21. Global Immune-Nutrition-Information Index Is Independent Prognostic Factor for Gastric Cancer Patients Who Received Curative Treatment.
    Aoyama T; Hashimoto I; Maezawa Y; Hara K; Yamamoto S; Esashi R; Tamagawa A; Cho H; Tanabe M; Morita J; Numata M; Kawahara S; Oshima T; Saito A; Yukawa N
    Cancer Diagn Progn; 2024; 4(4):489-495. PubMed ID: 38962545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Clinical Impact of the Prognostic Immune and Nutritional Index in Gastric Cancer Patients Who Received Curative Treatment.
    Aoyama T; Hashimoto I; Maezawa Y; Hara K; Tamagawa A; Cho H; Morita J; Tanabe M; Numata M; Kawahara S; Oshima T; Saito A; Yukawa N
    Anticancer Res; 2024 May; 44(5):2231-2238. PubMed ID: 38677750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic Significance of the Preoperative Ratio of C-Reactive Protein to Albumin and Neutrophil-Lymphocyte Ratio in Gastric Cancer Patients.
    Saito H; Kono Y; Murakami Y; Shishido Y; Kuroda H; Matsunaga T; Fukumoto Y; Osaki T; Ashida K; Fujiwara Y
    World J Surg; 2018 Jun; 42(6):1819-1825. PubMed ID: 29270656
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Systemic Immune-inflammation Index Is an Independent Prognostic Factor for Gastric Cancer Patients Who Receive Curative Treatment.
    Aoyama T; Maezawa Y; Hashimoto I; Yamamoto S; Esashi R; Hara K; Tamagawa A; Cho H; Tanabe M; Morita J; Kazama K; Numata M; Kawahara S; Oshima T; Saito A; Yukawa N
    In Vivo; 2024; 38(4):2001-2008. PubMed ID: 38936948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunonutritive Scoring for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: Evaluation of the CALLY Index.
    Müller L; Hahn F; Mähringer-Kunz A; Stoehr F; Gairing SJ; Michel M; Foerster F; Weinmann A; Galle PR; Mittler J; Pinto Dos Santos D; Pitton MB; Düber C; Kloeckner R
    Cancers (Basel); 2021 Oct; 13(19):. PubMed ID: 34638502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. C-reactive protein/albumin ratio is a poor prognostic factor of esophagogastric junction and upper gastric cancer.
    Kudou K; Saeki H; Nakashima Y; Kamori T; Kawazoe T; Haruta Y; Fujimoto Y; Matsuoka H; Sasaki S; Jogo T; Hirose K; Hu Q; Tsuda Y; Kimura K; Ando K; Oki E; Ikeda T; Maehara Y
    J Gastroenterol Hepatol; 2019 Feb; 34(2):355-363. PubMed ID: 30119141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prealbumin and lymphocyte-based prognostic score, a new tool for predicting long-term survival after curative resection of stage II/III gastric cancer.
    Shen Q; Liu W; Quan H; Pan S; Li S; Zhou T; Ouyang Y; Xiao H
    Br J Nutr; 2018 Dec; 120(12):1359-1369. PubMed ID: 30370885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Impact of the Lymphocyte-to-Monocyte Ratio in Patients With Gastric Cancer who Received Curative Treatment.
    Aoyama T; Hashimoto I; Maezawa Y; Hara K; Tamagawa A; Cho H; Numata M; Morita J; Tanabe M; Kawahara S; Oshima T; Saito A; Yukawa N; Rino Y
    Anticancer Res; 2024 Apr; 44(4):1567-1574. PubMed ID: 38537996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complete blood count-based inflammatory score (CBCS) is a novel prognostic marker for gastric cancer patients after curative resection.
    Lin JX; Lin JP; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu R; Zheng CH; Huang CM; Li P
    BMC Cancer; 2020 Jan; 20(1):11. PubMed ID: 31906893
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Controlling Nutritional Status (CONUT) score is a prognostic marker for gastric cancer patients after curative resection.
    Kuroda D; Sawayama H; Kurashige J; Iwatsuki M; Eto T; Tokunaga R; Kitano Y; Yamamura K; Ouchi M; Nakamura K; Baba Y; Sakamoto Y; Yamashita Y; Yoshida N; Chikamoto A; Baba H
    Gastric Cancer; 2018 Mar; 21(2):204-212. PubMed ID: 28656485
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of C-reactive protein-albumin-lymphocyte (CALLY) index on the prognosis of patients with distal cholangiocarcinoma following pancreaticoduodenectomy.
    Tsunematsu M; Haruki K; Taniai T; Tanji Y; Shirai Y; Furukawa K; Uwagawa T; Onda S; Yanagaki M; Usuba T; Nakabayashi Y; Okamoto T; Ikegami T
    Ann Gastroenterol Surg; 2023 May; 7(3):503-511. PubMed ID: 37152771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The C-reactive protein-albumin-lymphocyte (CALLY) index is a useful predictor of postoperative complications in patients with a colonic stent for obstructive colorectal cancer: a Japanese multicenter study.
    Shiraishi T; Nonaka T; Tominaga T; Takamura Y; Oishi K; Hashimoto S; Noda K; Ono R; Hisanaga M; Takeshita H; Ishii M; Oyama S; Ishimaru K; Kunizaki M; Sawai T; Matsumoto K
    Surg Today; 2024 Aug; ():. PubMed ID: 39177756
    [TBL] [Abstract][Full Text] [Related]  

  • 33. C-reactive protein-albumin-lymphocyte index as a feasible nutrition-immunity-inflammation marker of the outcome of all-cause and cardiovascular mortality in elderly.
    Luo L; Li M; Xi Y; Hu J; Hu W
    Clin Nutr ESPEN; 2024 Oct; 63():346-353. PubMed ID: 38985666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postoperative ratio of the maximum C-reactive protein level to the minimum peripheral lymphocyte count as a prognostic indicator for gastric cancer patients.
    Kono Y; Saito H; Murakami Y; Shishido Y; Kuroda H; Matsunaga T; Yamamoto M; Fukumoto Y; Osaki T; Ashida K; Fujiwara Y
    Surg Today; 2019 Mar; 49(3):206-213. PubMed ID: 30317493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Higher CALLY index levels indicate lower sarcopenia risk among middle-aged and elderly community residents as well as hospitalized patients.
    Li Y; Wei Q; Ke X; Xu Y; Xu B; Zhang K; Zhu W; Lian X; Liu L; Guo Z
    Sci Rep; 2024 Oct; 14(1):24591. PubMed ID: 39426987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lymphocyte-to-C-reactive protein ratio and score are clinically feasible nutrition-inflammation markers of outcome in patients with gastric cancer.
    Okugawa Y; Toiyama Y; Yamamoto A; Shigemori T; Ichikawa T; Yin C; Suzuki A; Fujikawa H; Yasuda H; Hiro J; Yoshiyama S; Ohi M; Araki T; McMillan DC; Kusunoki M
    Clin Nutr; 2020 Apr; 39(4):1209-1217. PubMed ID: 31155370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Postoperative ratio of C-reactive protein to albumin is an independent prognostic factor for gastric cancer.
    Li C; Yang X; Li H; Fu Y; Wang W; Jin X; Bian L; Peng L
    Eur J Med Res; 2023 Sep; 28(1):360. PubMed ID: 37735699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between the C-Reactive Protein-Albumin-Lymphocyte (CALLY) Index and Adverse Clinical Outcomes in CAD Patients after PCI: Findings of a Real-World Study.
    Pan Y; Wu TT; Deng CJ; Jiang ZH; Yang Y; Hou XG; Yan T; Wang S; Feng YJ; Zheng YY; Xie X
    Rev Cardiovasc Med; 2024 Apr; 25(4):111. PubMed ID: 39076545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Albumin-Bilirubin Score Is a Prognostic Factor for Gastric Cancer Patients Who Receive Curative Treatment.
    Ju M; Aoyama T; Komori K; Tamagawa H; Tamagawa A; Maezawa Y; Morita J; Onodera A; Endo K; Hashimoto I; Kano K; Hara K; Cho H; Nakazono M; Segami K; Ishiguro T; Onuma S; Oshima T; Yukawa N; Rino Y
    Anticancer Res; 2022 Aug; 42(8):3929-3935. PubMed ID: 35896262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Associations of C-reactive protein-albumin-lymphocyte (CALLY) index with cardiorenal syndrome: Insights from a population-based study.
    Xu Z; Tang J; Xin Chen ; Jin Y; Zhang H; Liang R
    Heliyon; 2024 Sep; 10(17):e37197. PubMed ID: 39296012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.